If you aren’t thinking bold enough you’ll never be ambitious enough!
— Jim Carroll
The opportunity
Accelerate the identification of potential drug candidates, predict their efficacy and safety, and streamline clinical trial processes, bringing life-saving medicines to patients faster.
From “Daily Inspiration: Business Model Transformation - “If you aren’t thinking bold enough you’ll never be ambitious enough!”” (January 2024)
do faster analysis of massive data sets from discovery trials
Perhaps the biggest trend is that AI will help us align to the emerging disruptive ‘real-time trial’ trend - with medical device connectivity and more, we now can gain instant, real-time information on how well a candidate molecule might be working, helping us to compress the drug development cycle.
a 20% reduction in the cost of 20 drug development programs at Johnson & Johnson
From “AI Megatrends - AI In Healthcare - Why the Acceleration of Knowledge Will Be the Biggest Challenge!” (April 2023)
Personalized medicine : AI is being used to analyze a patient’s genetic and molecular data to create personalized treatment plans, including personalized drug therapies. AI can predict how different patients will respond to different treatments, reducing trial and error in drug development.
Drug discovery : AI is being used to identify new drug candidates by analyzing large volumes of data, including genetic data and chemical structures. This can reduce the time and cost of drug development and lead to more effective treatments.
Clinical trial design: AI can be used to design clinical trials that are more efficient and effective, reducing the time and cost of drug development.
From “Decoding Tomorrow: The Way Forward: #4 Healthcare: “Yesterday’s medical breakthrough was a new drug. Tomorrow’s breakthrough is the intelligent algorithm that designs the drug, the connected device that delivers it, and the data stream that confirms it worked.”” (September 2025)
AI-driven diagnostics and treatment : Artificial intelligence is becoming the new engine of healthcare, used to analyze medical images, accelerate drug discovery, and create personalized treatment plans.
What does it lead to? Consider the global regenerative medicine market, which is projected to surge from $35.47 billion in 2024 to $90.01 billion by 2030 - we’ll soon be growing human body parts. That might be a bit of a stretch, but maybe not. Then there is the promise that gene therapy is finally being realized. In 2023, the FDA granted special designation to EDIT-301, a groundbreaking CRISPR gene-editing drug for severe sickle cell disease. In one remarkable case, a bespoke CRISPR treatment for a rare genetic disorder was developed for an infant in under six months, a feat made possible only through rapid collaboration across academia, industry, and regulators.
ICON PLC **: This global clinical trial powerhouse is at the forefront of leveraging AI to solve one of the biggest problems in drug development: the fact that 80% of clinical trials fail to meet their enrollment deadlines. My keynote for their CEO-level leadership meeting in Dublin was a deep dive into how they could use AI to disrupt their own business model—by identifying candidate molecules faster, predicting patient response to treatments, and accelerating the entire clinical trial process.
Read the full pieces on jimcarroll.com:
Daily Inspiration: Business Model Transformation - “If you aren’t thinking bold enough you’ll never be ambitious enough!”
AI Megatrends - AI In Healthcare - Why the Acceleration of Knowledge Will Be the Biggest Challenge!
Decoding Tomorrow: The Way Forward: #4 Healthcare: “Yesterday’s medical breakthrough was a new drug. Tomorrow’s breakthrough is the intelligent algorithm that designs the drug, the connected device that delivers it, and the data stream that confirms it worked.”